Literature DB >> 31876618

Menopause and risk of hip fracture in middle-aged Chinese women: a 10-year follow-up of China Kadoorie Biobank.

Ke Peng1,2,3, Pang Yao3, Christiana Kartsonaki3, Ling Yang3, Derrick Bennett3, Maoyi Tian2,4, Liming Li5, Yu Guo6, Zheng Bian6, Yiping Chen3, Zhengming Chen3, Rebecca Ivers1,2,7, Mark Woodward2,8,9, Robert Clarke3.   

Abstract

OBJECTIVE: Bone loss is accelerated after menopause in women, as is the risk of hip fracture, but little is known about the importance of age at menopause, time since menopause, and total reproductive years for risk of hip fracture.
METHODS: Between 2004 and 2008, the China Kadoorie Biobank recruited 125,336 postmenopausal women who had a natural menopause and recorded 1,327 incident cases of hip fracture during the first 10 years of follow-up. Multivariable Cox regression was used to estimate hazard ratios and 95% CIs for incident hip fracture for age at menopause, time since menopause, and total reproductive years.
RESULTS: The mean (SD) age at menopause was 48.8 (4.0) years. Compared with women who reached menopause before age 53 years, women with a later age at menopause had a 22% (95% CI, 11%-35%) lower risk of hip fracture. Compared with women who were <5 years since menopause, those who were 5 to 9, 10 to 14, 15 to 19, and ≥20 years since menopause had hazard ratios of hip fracture of 1.43 (95% CI, 1.01-2.04), 2.10 (95% CI, 1.71-2.57), 2.50 (95% CI, 2.21-2.83), and 2.33 (95% CI, 1.97-2.75), respectively. Women with a longer (≥36 y) versus shorter (<30 y) duration of total reproductive years had a 19% (95% CI, 9-28) lower risk of hip fracture.
CONCLUSIONS: Women with younger age at menopause, longer interval since menopause, or shorter duration of total reproductive years had the highest risks of hip fracture.

Entities:  

Mesh:

Year:  2020        PMID: 31876618     DOI: 10.1097/GME.0000000000001478

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   3.310


  2 in total

1.  [Detection of DNA methylation of HYAL2 gene for differentiating malignant from benign thyroid tumors].

Authors:  Y Yin; H Li; C Yang; M Zhang; X Huang; M Li; R Yang; Z Zhang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-01-20

2.  Risk of peripheral artery occlusive disease in patients with lower leg fracture who received fixation and non-fixation treatments: A population cohort study.

Authors:  Pin-Keng Shih; Jian-Xun Chen; Mei-Chen Lin; Shih-Chi Wu
Journal:  PLoS One       Date:  2022-08-04       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.